Objectives:The current study is concerned with creating a Zn(II) complex with a novel schiff base ligand and to evaluate the Zn(II) metal complex's in-vitro antifungal efficacy against Candida albicans, Candida glabrata, Candida krusei, and Candida tropicali. Methods: N, N'-bis(2-hydroxy-3methoxybenzaldehyde)-2-phenyl-1,3-propanediamine was synthesized by using 2-hydroxy-3-methoxybenzaldehyde and 2-phenyl-1,3-propanediamine. Metal precursor Zn(OAc) 2 .2H 2 O react with the ligand to form Zn(II) metal complex. The structure of the synthesis complex was confirmed by elemental analysis i.e. 1H-NMR, IR and MS spectroscopy. Findings : Zn(II) schiff base complexes have unique characteristics and unusual reactivity, which operate as a foundation for the development of complex molecules with potential use in a wide range of applications. One of the most typical fungal infections is candidiasis. The findings suggest that the Zn(II) metal complex could be a promising antifungal agent. Novelty: Characterization and unique properties of the newly synthesized zinc complex and its potential as a novel class of antifungal agent.